Athena on Boards | Cohort 6
March 2021- July 2021
POWERED BY COOLEY
VP, Scientific Strategy & Corporate Development | Zogenix
SVP, Accounting & Corporate Controller | Mitchell International
Chief Scientific Officer | Gossamer Bio
ANILA DHOKIA
VP, Internal Audit & ERM | Illumina
Sr. Director, Alliance Management & Program Lead | Halozyme
MONIQUE LEVY
Chief Commercial & Strategy Officer | Woebot Health
Sr. Director Product Management, Applications, & Services | Thermo Fisher Scientific
VP, Global Finance | NuVasive
CEO | Key Tech
Consultant & Science Journalist
Chief Medical Officer | Neurocrine Biosciences
VP, Assay Development | Genmark Diagnostics
Sr. Manager, Global Market Development | Thermo Fisher Scientific
President | Portavoce PR
Founder & CEO | Reveal Biosciences
VP, Human Resources | Genmark Diagnostics
VP, Finance & Corporate Secretary | Ambrx Inc.
Contact Athena CEO, Holly Smithson to secure your spot on the waitlist
for the next cohort and design your board search through Athena’s On Boards Series.
Athena on Boards Mentors
Chief Operations Officer | Upfront Resolution
CEO | RippleNami Inc.
VP, Corporate Marketing & Communications | Seer
Athena on Boards Committee
CO-CHAIR: JAYE CONNOLLY-LABELLE
CEO | RippleNami Inc.
CO-CHAIR: CHARITY WILLIAMS
Partner | Cooley
Head of IT Program Office | Jack In The Box
Chief Financial Officer | Correlation Ventures
Audit Partner | BDO